Gerald Bruce
Chief Executive Officer chez VIRPAX PHARMACEUTICALS, INC.
Fortune : 1 721 $ au 31/03/2024
Profil
Gerald W.
Bruce is currently the Chief Executive Officer & Director at Virpax Pharmaceuticals, Inc. He is also a Director at National Sales Network and a Trustee at Lincoln University (Pennsylvania).
Previously, he worked at Johnson & Johnson as a Group Product Director-Analgesics from 1983 to 1998.
From 1998 to 2006, he served as the Vice President-Managed Markets at Bristol Myers Squibb Co. He then worked as the Senior Vice President-Commercial Operations at NitroMed, Inc. from 2006 to 2008.
From 2009 to 2018, he held the position of Vice President-Sales at Nutricia North America, Inc. Mr. Bruce completed his undergraduate degree at Lincoln University (Pennsylvania) and his graduate degree at McDonough School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 22/03/2024 | 404 ( 0,03% ) | 1 721 $ | 31/03/2024 |
Postes actifs de Gerald Bruce
| Sociétés | Poste | Début |
|---|---|---|
| VIRPAX PHARMACEUTICALS, INC. | Chief Executive Officer | 20/11/2023 |
| National Sales Network | Director/Board Member | - |
| Lincoln University (Pennsylvania) | Director/Board Member | - |
Anciens postes connus de Gerald Bruce
| Sociétés | Poste | Fin |
|---|---|---|
Nutricia North America, Inc.
 Nutricia North America, Inc. Pharmaceuticals: OtherHealth Technology Part of Danone SA, Nutricia North America, Inc. is a health company that specializes in advanced medical nutrition for specialized care and memory health. The private company is based in Gaithersburg, MD. Nutricia products and services improve the daily lives of millions of people, from infants to aging seniors, by providing quality medical food and formulas. The company's research facility, supported by over 150 PhDs, develops trusted and effective products for a better, healthier life. Nutricia partners with over 50 university research centers worldwide and is committed to clinical research and improving medical nutrition for specialized care through trials, studies, and academic collaboration. The CEO of the company is Nigel P. Hughes. | Sales & Marketing | 01/11/2018 |
NitroMed, Inc.
 NitroMed, Inc. Pharmaceuticals: MajorHealth Technology NitroMed, Inc. develops and supplies pharmaceuticals. It offers BiDil, an orally administered medicine for the treatment of heart failure. The firm also develops products for cardiovascular and metabolic diseases. The company was founded in 1987 and is headquartered in Atlanta, GA. | Corporate Officer/Principal | 01/06/2008 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/01/2006 |
| JOHNSON & JOHNSON | Corporate Officer/Principal | 01/09/1998 |
Formation de Gerald Bruce
| Lincoln University (Pennsylvania) | Undergraduate Degree |
| McDonough School of Business | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| JOHNSON & JOHNSON | Health Technology |
| Entreprise privées | 4 |
|---|---|
NitroMed, Inc.
NitroMed, Inc. Pharmaceuticals: MajorHealth Technology NitroMed, Inc. develops and supplies pharmaceuticals. It offers BiDil, an orally administered medicine for the treatment of heart failure. The firm also develops products for cardiovascular and metabolic diseases. The company was founded in 1987 and is headquartered in Atlanta, GA. | Health Technology |
Nutricia North America, Inc.
Nutricia North America, Inc. Pharmaceuticals: OtherHealth Technology Part of Danone SA, Nutricia North America, Inc. is a health company that specializes in advanced medical nutrition for specialized care and memory health. The private company is based in Gaithersburg, MD. Nutricia products and services improve the daily lives of millions of people, from infants to aging seniors, by providing quality medical food and formulas. The company's research facility, supported by over 150 PhDs, develops trusted and effective products for a better, healthier life. Nutricia partners with over 50 university research centers worldwide and is committed to clinical research and improving medical nutrition for specialized care through trials, studies, and academic collaboration. The CEO of the company is Nigel P. Hughes. | Health Technology |
| National Sales Network | |
| Virpax Pharmaceuticals, Inc. |
